LENZ   $3.915  5.24% Market Closed After Close 3.96 1.15%

LENZ Therapeutics, Inc.
Total Cash 196.11M
totalCashPerShare 7.132
EBITDA -75.26M
Total Debt 1.70M
quickRatio 22.849
currentRatio 23.226
Total Revenue
debtToEquity 0.882
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -73.79M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 573.57M
forwardPE -10.344444
floatShares 12.51M
sharesOutstanding 27.50M
sharesShort 1.95M
sharesShortPriorMonth 1.92M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.86%
Short Ratio help_outline 11.67%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 7.464
Price To Book help_outline 3.74
earningsQuarterlyGrowth
netIncomeToCommon -69.47M
trailingEps -2.74%
forwardEps -2.70%
enterpriseToEbitda -7.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.46 3Q 2024
institutionsCount 108
lastUpdated Nov. 2, 2024, 7:15 a.m.